체외막산소화(ECMO) 기계 시장 규모, 점유율, 성장 분석 : 컴포넌트별, 모달리티별, 환자 연령층별, 용도별, 최종사용자별, 지역별 - 업계 예측(2025-2032년)

Global Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 311.4 million in 2023 and is poised to grow from USD 328.22 million in 2024 to USD 499.9 million by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).

The global market for extracorporeal membrane oxygenation (ECMO) machines is experiencing steady growth as this vital technology becomes integral in managing severe cardiac and respiratory failures when conventional treatments fall short. Factors fueling demand include advancements in critical care infrastructures, rising prevalence of cardiopulmonary diseases, and broader acceptance of ECMO in clinical practices. Innovations such as increased portability, use of biocompatible materials, and integrated monitoring systems are on the horizon, enhancing usability in emergency scenarios. The establishment of specialized ECMO centers and trained multidisciplinary teams is further propelling adoption. However, challenges remain, including the high costs of machines, a shortage of skilled professionals, complexities in managing ECMO, and uncertainties in reimbursement and regulation, particularly in emerging markets, which may hinder broader implementation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Extracorporeal Membrane Oxygenation Machine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Extracorporeal Membrane Oxygenation Machine Market Segments Analysis

Global Extracorporeal Membrane Oxygenation Machine Market is segmented by Component, Modality, Patient Age Group, Application, End-User and region. Based on Component, the market is segmented into Pumps, Oxygenators, Controllers, Cannula & Tubing Sets and Accessories & Consumables. Based on Modality, the market is segmented into Veno-Venous (VV), Veno-Arterial (VA) and Arterio-Venous (AV). Based on Patient Age Group, the market is segmented into Neonates, Pediatrics and Adults. Based on Application, the market is segmented into Respiratory Disorders, Cardiac Conditions and Extracorporeal Cardiopulmonary Resuscitation (ECPR). Based on End-User, the market is segmented into Hospitals (ICU / Cardiac Care Units), Specialty Clinics and Emergency Medical Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Extracorporeal Membrane Oxygenation Machine Market

One of the key market drivers for the global extracorporeal membrane oxygenation (ECMO) machine market is the increasing prevalence of respiratory and cardiac diseases that require advanced life-support systems. As the incidence of conditions such as acute respiratory distress syndrome (ARDS), heart failure, and severe pneumonia rises, the demand for ECMO technology has surged in healthcare institutions. Additionally, advancements in ECMO technology, including improvements in portable systems and increased efficacy, have bolstered its adoption in critical care settings. This growing recognition of ECMO's role in saving lives during severe health crises significantly contributes to the expansion of the market.

Restraints in the Global Extracorporeal Membrane Oxygenation Machine Market

A significant restraint in the global extracorporeal membrane oxygenation (ECMO) machine market is the high cost of ECMO systems and their associated components. The substantial financial investment required for procurement, maintenance, and operation can be a major hurdle for healthcare facilities, particularly in developing regions with limited budgets and resources. Additionally, the shortage of trained healthcare professionals to operate these sophisticated machines can hinder their implementation, leading to underutilization. Furthermore, regulatory challenges and the complexity involved in training personnel pose additional barriers that could slow market growth and adoption rates across various healthcare settings worldwide.

Market Trends of the Global Extracorporeal Membrane Oxygenation Machine Market

The Global Extracorporeal Membrane Oxygenation (ECMO) Machine market is witnessing a significant trend toward the development of portable and user-friendly systems. Manufacturers are focusing on creating compact, lightweight ECMO machines that facilitate their use beyond traditional intensive care units, enabling effective treatment even in smaller healthcare facilities or during patient transport. These advancements lead to quicker setup times, thereby enhancing accessibility to ECMO therapy, particularly in rural and resource-limited environments. As healthcare providers increasingly prioritize mobility and ease of use, the market is transforming to meet the evolving needs of patient care, ultimately improving clinical outcomes and operational efficiency.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Raw Material Analysis

Global Extracorporeal Membrane Oxygenation Machine Market Size by Component & CAGR (2025-2032)

• Market Overview
• Pumps
• Oxygenators
• Controllers
• Cannula & Tubing Sets
• Accessories & Consumables

Global Extracorporeal Membrane Oxygenation Machine Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Veno-Venous (VV)
• Veno-Arterial (VA)
• Arterio-Venous (AV)

Global Extracorporeal Membrane Oxygenation Machine Market Size by Patient Age Group & CAGR (2025-2032)

• Market Overview
• Neonates
• Pediatrics
• Adults

Global Extracorporeal Membrane Oxygenation Machine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Respiratory Disorders
• Cardiac Conditions
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Global Extracorporeal Membrane Oxygenation Machine Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals (ICU / Cardiac Care Units)
• Specialty Clinics
• Emergency Medical Services

Global Extracorporeal Membrane Oxygenation Machine Market Size & CAGR (2025-2032)

• North America (Component, Modality, Patient Age Group, Application, End-User)
  • US
  • Canada
• Europe (Component, Modality, Patient Age Group, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Modality, Patient Age Group, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Modality, Patient Age Group, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Modality, Patient Age Group, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Cardiovascular Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurosets S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maquet Holding (Getinge Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSorbents Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medos Medizintechnik AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microport Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (ECLS division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xenios AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saranas Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxygen Plus Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemovent GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abiomed Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (ICU Life Support Division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations